×
For best experience we recommend to activate Javascript in your browser.
CLCF1 antibody (N-Term)
The Rabbit Polyclonal anti-CLCF1 antibody has been validated for WB and ELISA. It is suitable to detect CLCF1 in samples from Human.
Quick Overview for CLCF1 antibody (N-Term) (ABIN2234387)
Target
See all CLCF1 Antibodies
CLCF1
(Cardiotrophin-Like Cytokine Factor 1 (CLCF1))
Reactivity
All reactivities for CLCF1 antibodies
Human
Host
All hosts for CLCF1 antibodies
Rabbit
Clonality
All clonalities for CLCF1 antibodies
Polyclonal
Conjugate
All conjugates for CLCF1 antibodies
This CLCF1 antibody is un-conjugated
Application
All applications for CLCF1 antibodies
Western Blotting (WB), ELISA
Product Details anti-CLCF1 Antibody
(hide)
Binding Specificity
All epitopes for CLCF1 antibodies
AA 45-72, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
CLCF1, NT (CLCF1, BSF3, CLC, NNT1, Cardiotrophin-like cytokine factor 1, B Cell-stimulating factor 3, Novel neurotrophin-1)
Purification
Purified by Protein A affinity chromatography.
Immunogen
CLCF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic between 45-72 amino acids selected from the N-terminal region of human CLCF1.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for CLCF1
(hide)
Target
CLCF1
(Cardiotrophin-Like Cytokine Factor 1 (CLCF1))
Alternative Name
CLCF1
NCBI Accession
NP_001159684
UniProt
Q9UBD9
Pathways
Regulation of Leukocyte Mediated Immunity , Positive Regulation of Immune Effector Process , Production of Molecular Mediator of Immune Response
Recently viewed
(hide)
Chat with us , powered by LiveChat